Dabur India Ltd has informed the Exchange that the Board of Directors of Dabur India Limited ("DIL" or "Transferee Company") at their meeting held on October 26, 2009 have considered and approved the Scheme for Amalgamation of Fem Care Pharma Limited ("FCPL or Transferor Company") with DIL as per terms and conditions mentioned in the Scheme of Amalgamation ("the Scheme") under the provisions of Sections 391 to 394 of the Companies Act, 1956. The salient Features of the Scheme are as under : 1) The Appointed Date for merger under the Scheme is April 1, 2009. 2) In consideration of the Amalgamation of FCPL with DIL, the Company shall allot 5 (five) Equity Share(s) of the face value of Re. 1 each credited as fully paid-up, for every 1 (one) Equity Share of the face value of Rs. 10 each held by the shareholders of FCPL. 3) As a result of the merger, the portion of share capital of FCPL held by DIL (i.e., 32,52,476 equity shares) shall stand cancelled and there would be no issuance of shares by the DIL in relation to such shares . 4) The Scheme is subject to requisite consent/ approval of the shareholders, lenders, creditors of the Company, and sanction of the Honble High Court of Judicature at Delhi and Honble High Court of Judicature at Bombay and the permission or approval of any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme.

please guide me /what will happen to 100 physical shares of FEM CARE PHARMA i hold since its public issue .

please guide

Benefit of any kind should be sent to you in which shape your are holding! However you should contact any of share broker for second opinion?